Agios Pharmaceuticals Inc Market cap
What is the Market cap of Agios Pharmaceuticals Inc?
The Market cap of Agios Pharmaceuticals Inc is $1.70B
What is the definition of Market cap?
Market capitalization is the market value at a point in time of the shares outstanding of a publicly traded company, being equal to the share price at that point of time times the number of shares outstanding.
= outstanding shares * previous day’s close
As outstanding stock is bought and sold in public markets, capitalization could be used as an indicator of public opinion of a company's net worth and is a determining factor in some forms of stock valuation.
Market capitalization is used by the investment community in ranking the size of companies, as opposed to sales or total asset figures. It is also used in ranking the relative size of stock exchanges, being a measure of the sum of the market capitalizations of all companies listed on each stock exchange. In performing such rankings, the market capitalizations are calculated at some significant date, such as 30 June or 31 December.
The total capitalization of stock markets or economic regions may be compared with other economic indicators. The total market capitalization of all publicly traded companies in the world was US$51.2 trillion in January 2007 and rose as high as US$57.5 trillion in May 2008 before dropping below US$50 trillion in August 2008 and slightly above US$40 trillion in September 2008. In 2014 and 2015, global market capitalization was US$68 trillion and US$67 trillion, respectively.
Market cap of companies in the Health Care sector on NASDAQ compared to Agios Pharmaceuticals Inc
What does Agios Pharmaceuticals Inc do?
at agios, we are doing incredibly important and difficult work. we are trying to discover and develop breakthrough medicines, and we have a clear motivator — people with cancer and rare genetic diseases who are counting on us to be successful. we are a science-driven research organization. we have built a discovery platform upon our expertise in the fields of cellular metabolism and precision medicine across three major focus areas: cancer metabolism, rare genetic metabolic disorders and metabolic immuno-oncology. it takes people with a diversity of thought, skills, passions and backgrounds to get us from the first stages of understanding new biology and discovering drugs to our ultimate goal of getting these medicines to patients who are waiting for them. our connection to one another and our work and our commitment to our values enable us to potentially change the practice of medicine by by striving for excellence and doing things differently. we call this the "other side of possible
Companies with market cap similar to Agios Pharmaceuticals Inc
- Pacific Basin Shipping has Market cap of $1.70B
- Materion Corp has Market cap of $1.70B
- Lovisa has Market cap of $1.70B
- Lifeworks Inc has Market cap of $1.70B
- The Star Entertainment has Market cap of $1.70B
- Jia Yuan Technology has Market cap of $1.70B
- Agios Pharmaceuticals Inc has Market cap of $1.70B
- XPEL Inc has Market cap of $1.70B
- Maruwa Co has Market cap of $1.70B
- Pantheon International Plc has Market cap of $1.71B
- Atlanta Braves Inc has Market cap of $1.71B
- Huabao International has Market cap of $1.71B
- Nuveen Municipal Credit Income Fund has Market cap of $1.71B